Galectin Therapeutics's market cap is currently $76.02M. The company's EPS TTM is $-0.728; its P/E ratio is ―; Galectin Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -33.00K	$ -32.00K	$ -41.00K	$ -36.00K	$ -35.00K
Operating Income	$ -38.07M	$ -38.35M	$ -30.18M	$ -23.44M	$ -13.44M
EBITDA	$ -202.00K	$ -37.71M	$ -30.00M	$ -23.34M	$ -13.17M
Net Income	$ -41.07M	$ -39.20M	$ -30.98M	$ -23.52M	$ -13.38M
Balance Sheet
Cash & Short-Term Investments	$ 25.66M	$ 18.59M	$ 39.65M	$ 27.14M	$ 47.48M
Total Assets	$ 28.20M	$ 21.29M	$ 41.83M	$ 29.60M	$ 48.47M
Total Debt	$ 71.81M	$ 39.87M	$ 29.06M	$ 44.00K	$ 39.00K
Net Debt	$ 46.15M	$ 21.28M	$ -10.59M	$ -27.10M	$ -47.44M
Total Liabilities	$ 88.44M	$ 55.20M	$ 40.93M	$ 5.41M	$ 2.87M
Stockholders' Equity	$ -60.24M	$ -33.92M	$ 893.00K	$ 29.60M	$ 45.59M
Cash Flow
Free Cash Flow	$ -32.97M	$ -31.06M	$ -24.31M	$ -20.60M	$ -10.85M
Operating Cash Flow	$ -32.97M	$ -31.06M	$ -24.31M	$ -20.60M	$ -10.85M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 40.03M	$ 10.00M	$ 36.81M	$ 263.00K	$ 50.08M

Currency in USD

Galectin Therapeutics Earnings and Revenue History

Income Statement >

Galectin Therapeutics Debt to Assets

Balance Sheet >

Galectin Therapeutics Cash Flow

Cash Flow >

Galectin Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing